GGH/HuR複合体は,mRNAを結合し安定させ,腫瘍細胞サイクルとDNA複製を維持する
Yu Li1,2, Xinrui Li2, Yuhui Du2,3
1Department of Critical Care Medicine, Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|August 20, 2025
まとめ
ガンマグルタミルヒドローラゼ (GGH) は,重要なmRNAを安定させ,細胞の成長を促すことで,肺がんにおける腫瘍遺伝子として作用する. GGHの静止は腫瘍の進行を阻害し 潜在的治療目標として強調しました
科学分野:
- 分子生物学
- 腫瘍学
- 生物化学
背景:
- ガンマ・グルタミル・ヒドローラゼ (GGH) は,がんにおいて高い発現率を持つ葉酸代謝酵素である.
- 腫瘍の進行における腫瘍遺伝子の役割と基礎的なメカニズムは完全に理解されていません.
研究 の 目的:
- 肺がんにおけるGGHの腫瘍学的機能を調査する.
- GGHが腫瘍の進行を促す分子メカニズムを解明する.
主な方法:
- 肺がん細胞におけるGGH遺伝子静止 (in vitroおよびin vivo)
- mRNA標的と結合モチーフを特定するためのRNA結合測定法.
- タンパク質とRNAの相互作用 (GGH,HuR) を研究するための共免疫プレシピテーション
- 肺がん組織におけるGGH発現の分析と患者の生存率との相関
主要な成果:
- GGHの静止は肺がん細胞の増殖を 顕著に抑制しました
- GGHはRNA結合タンパク質として機能し,CDC6やCCND1のような標的mRNAを安定させます.
- GGHはHuRと相互作用し,mRNAの安定性を高める三元複合体を形成する.
- 肺がん組織における高GGH発現は,患者の生存率の低下と相関する.
結論:
- GGHは,非正規のRNA結合作用により,肺がんにおける腫瘍性機能を有する.
- GGHは細胞サイクルとDNA複製に関連するmRNAを安定させる.
- GGHは肺がん治療の潜在的治療標的である.
関連する概念動画
01:23Negative Regulator Molecules
35.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K
02:37DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:28The Cell Cycle Control System
3.5K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
3.5K
02:39Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K